scholarly article | Q13442814 |
P50 | author | Simon Anthony Young | Q47801834 |
Ilva D. Rupenthal | Q54195935 | ||
Ying-Shan Chen | Q114291015 | ||
Raid Ghassan Alany | Q37840315 | ||
Colin Green | Q37840331 | ||
P2860 | cites work | Oligonucleotide analogues as potential chemotherapeutic agents | Q39573965 |
Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. | Q40095319 | ||
Effect of various formulation parameters on the properties of polymeric nanoparticles prepared by multiple emulsion method | Q40308524 | ||
Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells | Q40618965 | ||
Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery | Q40713744 | ||
Microparticulate uptake mechanisms of in-vitro cell culture models of the respiratory epithelium | Q40824854 | ||
Antisense oligonucleotides as therapeutic agents--is the bullet really magical? | Q40834751 | ||
Preparation of microspheres by the solvent evaporation technique | Q43706872 | ||
Preparation and characterization of cationic PLGA nanospheres as DNA carriers. | Q44062476 | ||
Critical determinants in PLGA/PLA nanoparticle-mediated gene expression | Q44403133 | ||
Polymer degradation and in vitro release of a model protein from poly(d,l-lactide-co-glycolide) nano- and microparticles | Q44589782 | ||
PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution | Q45233463 | ||
Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency | Q46675585 | ||
Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. | Q47883515 | ||
Stabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probes. | Q47912118 | ||
Antisense down regulation of connexin31.1 reduces apoptosis and increases thickness of human and animal corneal epithelia | Q48030663 | ||
Efficient delivery of intact phosphodiester oligonucleotides by poly-beta-amino esters | Q49113556 | ||
Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles. | Q50941498 | ||
Expression of gap junction proteins Cx26, Cx31.1, Cx37, and Cx43 in developing and mature rat epidermis | Q28583153 | ||
Nonviral gene therapy: promises and challenges | Q33840998 | ||
The delivery of antisense therapeutics | Q34062621 | ||
Novel non-endocytic delivery of antisense oligonucleotides | Q34062631 | ||
Regulation of phagocytosis and endo-phagosomal trafficking pathways in Dictyostelium discoideum | Q34189270 | ||
Modeling and comparison of dissolution profiles | Q34215811 | ||
Chemical modification of gene silencing oligonucleotides for drug discovery and development | Q36101387 | ||
Innovative nanotechnologies for the delivery of oligonucleotides and siRNA. | Q36585342 | ||
State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers. | Q37213383 | ||
Molecular mechanisms of antisense drugs: RNase H. | Q38337536 | ||
Cellular uptake study of biodegradable nanoparticles in vascular smooth muscle cells | Q38549934 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 493-501 | |
P577 | publication date | 2011-06-22 | |
P1433 | published in | Drug Delivery | Q5308838 |
P1476 | title | In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides. | |
P478 | volume | 18 |
Q38765826 | Co-delivery of pemetrexed and miR-21 antisense oligonucleotide by lipid-polymer hybrid nanoparticles and effects on glioblastoma cells. |
Q58764302 | Folate and Borneol Modified Bifunctional Nanoparticles for Enhanced Oral Absorption |
Q64030465 | Förster Resonance Energy Transfer-Based Stability Assessment of PLGA Nanoparticles in Vitro and in Vivo |
Q50239899 | Low-intensity focused ultrasound mediated localized drug delivery for liver tumors in rabbits |
Q38119238 | Nanoparticles in the ocular drug delivery |
Search more.